Abstract
Atherosclerotic renovascular disease (ARVD) is a common condition in both elderly patients and those with other vascular disease. No published randomized controlled trial has demonstrated an overall benefit of revascularization on any clinical or biochemical end-point, and optimal medical therapy in this condition is not clearly defined. In this review we consider the epidemiology of ARVD and discuss the evidence for current medical treatment. We also address the literature on revascularization, consider settings in which an interventional approach may still be considered, and touch upon on-going areas of research. © 2012 Informa UK, Ltd.
| Original language | English |
|---|---|
| Pages (from-to) | S98-S110 |
| Journal | Annals of Medicine |
| Volume | 44 |
| Issue number | 1 |
| Publication status | Published - Jun 2012 |
Keywords
- Atheromatous renovascular disease
- medical therapy
- renal artery stenosis
- revascularization
